Application of physiologically-based pharmacokinetic model approach to predict pharmacokinetics and drug-drug interaction of rivaroxaban: A case study of rivaroxaban and carbamazepine.

Ngo LT, Yang SY, Shin S, Cao DT, Van Nguyen H, Jung S, Lee JY, Lee JH, Yun HY, Chae JW.

Open source

DOI: 10.1002/psp4.12844
Published: 2022-10-03
Container: CPT Pharmacometrics Syst Pharmacol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/psp4.12844,
  title = {Application of physiologically-based pharmacokinetic model approach to predict pharmacokinetics and drug-drug interaction of rivaroxaban: A case study of rivaroxaban and carbamazepine.},
  author = {Ngo LT and  Yang SY and  Shin S and  Cao DT and  Van Nguyen H and  Jung S and  Lee JY and  Lee JH and  Yun HY and  Chae JW.},
  year = {2022},
  journal = {CPT Pharmacometrics Syst Pharmacol},
  doi = {10.1002/psp4.12844},
  url = {https://doi.org/10.1002/psp4.12844}
}

RIS

TY  - JOUR
TI  - Application of physiologically-based pharmacokinetic model approach to predict pharmacokinetics and drug-drug interaction of rivaroxaban: A case study of rivaroxaban and carbamazepine.
AU  - Ngo LT
AU  -  Yang SY
AU  -  Shin S
AU  -  Cao DT
AU  -  Van Nguyen H
AU  -  Jung S
AU  -  Lee JY
AU  -  Lee JH
AU  -  Yun HY
AU  -  Chae JW.
PY  - 2022
JO  - CPT Pharmacometrics Syst Pharmacol
DO  - 10.1002/psp4.12844
UR  - https://doi.org/10.1002/psp4.12844
ER  -

APA

LT, N., SY, Y., S, S., DT, C., H, V. N., S, J., JY, L., JH, L., HY, Y., & JW., C. (2022). Application of physiologically-based pharmacokinetic model approach to predict pharmacokinetics and drug-drug interaction of rivaroxaban: A case study of rivaroxaban and carbamazepine.. CPT Pharmacometrics Syst Pharmacol. https://doi.org/10.1002/psp4.12844

Source records

europe-pmc · retrieved 2026-09-26T22:02:08.241Z
doaj · retrieved 2026-09-26T22:02:08.249Z